XPO1抑制剂
搜索文档
Karyopharm Therapeutics(KPTI) - 2025 Q4 - Earnings Call Transcript
2026-02-12 22:02
Karyopharm Therapeutics (NasdaqGS:KPTI) Q4 2025 Earnings call February 12, 2026 08:00 AM ET Company ParticipantsBrendan Strong - VP of Investor Relations and Corporate CommunicationsLori Macomber - CFO and TreasurerReshma Rangwala - EVP, Chief Medical Officer and Head of ResearchRichard Paulson - President and CEOSohanya Cheng - EVP, Chief Commercial Officer and Head of Business DevelopmentConference Call ParticipantsBrian Abrahams - Senior Biotechnology Analyst and Global Sector Head of Healthcare Research ...